Expanded Access to Immunomodulatory AVM0703 for Solid Tumor and Blood Cancer Patients
Status: AVAILABLE
Study type: EXPANDED_ACCESS
Conditions: Glioblastoma|Squamous Cell Carcinoma|Hodgkin Lymphoma|Non-hodgkin Lymphoma|Breast Cancer|Prostate Cancer|Gastric Cancer|Ovarian Cancer|Acute Leukemia|Pancreatic Cancer|Spindle Cell Sarcoma|Cancer|Tumor, Solid|Tumor, Brain
Interventions: DRUG: AVM0703|DRUG: Hydrocortisone|DRUG: Proton pump inhibitor
Sponsor: AVM Biotechnology Inc